Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04801797 |
Title | Venetoclax + Azacitidine vs. Induction Chemotherapy in AML |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Massachusetts General Hospital |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | RECRUITING | Duarte | California | 91010 | United States | Details |
Stanford Cancer Center | RECRUITING | Palo Alto | California | 94304 | United States | Details |
University of California - Davis | RECRUITING | Sacramento | California | 95817 | United States | Details |
Massachusetts General Hospital Cancer Center | RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
Beth Israel Deaconess Medical Center | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Atrium Health Levine Cancer Institute | RECRUITING | Charlotte | North Carolina | 28204 | United States | Details |
Ohio State University Medical Center | RECRUITING | Columbus | Ohio | 43210 | United States | Details |
University of Pennsylvania | RECRUITING | Philadelphia | Pennsylvania | 19104 | United States | Details |